Home / Explore Insights / Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life
/ Insights / Explore Insights / Autologous Hsct For Severe Progressive Multiple Sclerosis In A Multicenter Trial Impact On Disease Activity And Quality Of Life
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life
Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P, Donelli A, Filippi M, Guerrasio A, Gualandi F, La Nasa G, Murialdo A, Pagliai F, Papineschi F, Scappini B, Marmont AM
Blood
ADCT
03/14/2005
Publication